Canada already has an access problem when it comes to traditional abortions, so when news broke last year that Health Canada had approved Mifegymiso, an abortion pill, it looked like it would lead to more accessibility, especially in remote areas of the country. Sadly, this is not the case.

Unlike other prescription medications, Mifegymiso previously known as RU-486, can only be prescribed by those registered and trained in its use, putting it in the same category as methadone.  On top of that, Health Canada requires women to get an ultrasound before taking the pill to “exclude ectopic pregnancy and confirm gestational age” – another barrier for women in remote areas.

In the United States the same drug can be prescribed by any prescribing authority, including midwives, making it more accessible.

The Society of Obstetricians and Gynecologists of Canada is starting to train medical professionals this month, but won’t give details on what that training involves.

Looks like Canadian women aren’t any closer to accessible abortions.